Companies similar to Alaunos Therapeutics
Discover companies with a similar profile to Alaunos Therapeutics, surfaced using Canonical’s structured company search.
Funding record
Alaunos Therapeutics
Round amounts, dates, and lead investors are part of every company record in Canonical.
On file
Sign up to view
- Round
- Withheld
- Amount raised
- Withheld
- Announced
- Withheld
- Lead investor
- Withheld
| Company | Domain | Description | HQ location |
|---|---|---|---|
| Simnova | simnovabio.com | Simnova Bio is a clinical-stage biotechnology company dedicated to developing innovative cell therapies for cancer patients. Leveraging advanced NK cell and T cell platforms, alongside antibody discovery capabilities, the company aims to create targeted RNA therapeutics to address unmet medical needs in oncology. | Cambridge, Massachusetts, United States |
| Repertoire Immune Medicines | repertoire.com | Repertoire Immune Medicines is a biotechnology company focused on developing transformative and programmable immune medicines for patients with cancer and autoimmune diseases. They leverage their proprietary DECODE platform to understand the fundamental biology of the immune system and translate these insights into | Cambridge, Massachusetts, United States |
| AvenCell | avencell.com | Avencell is a biotechnology company focused on developing next-generation immunotherapies for cancer. They leverage proprietary allogeneic and switchable CAR platforms to create powerful, targeted, and safe treatments that address the limitations of current CAR-T cell therapies. Their mission is to advance cancer | Cambridge, Massachusetts, United States |
| T-knife | t-knife.com | T-knife Therapeutics is a biotechnology company focused on developing next-generation T cell therapies for solid tumors. They aim to create best-in-class treatments by "supercharging" T cells using proprietary platforms and synthetic biology. | San Francisco, California, United States |
| Lion TCR | liontcr.com | Lion TCR is a biotechnology company specializing in the development of personalized T cell receptor (TCR)-T cell therapies. They focus on treating life-threatening viral infections and viral-related cancers, with a particular emphasis on Hepatocellular Carcinoma (HCC) prevalent in Asia. Their mission is to provide | Singapore, Central Region, Singapore |
| Link Cell Therapies | linkcelltx.com | Link Cell Therapies is a biotechnology company focused on developing novel CAR T cell therapies. They utilize a unique "logic-gate" technology to enhance the specificity and safety of their cancer treatments. Their mission is to improve outcomes for patients with challenging cancers. | South San Francisco, California, United States |
| Bioheng Therapeutics | imvivabio.com | ImvivaBio is a clinical-stage biotechnology company developing allogeneic CAR-T cell therapies for cancers and autoimmune diseases. They leverage their proprietary Imviva platform and ANSWER™ technology to create "off-the-shelf" treatments. Their mission is to overcome manufacturing challenges and make advanced cell therapies more accessible. | Boston, Massachusetts, United States |
| T-Curx | t-curx.com | T-CURX is a biotechnology company focused on developing personalized immunotherapies using CAR-T cells. They aim to create transformative, one-shot, and chemotherapy-free treatments for cancer patients. Their proprietary technology enables the development of first- and best-in-class therapies with a focus on | Würzburg, Bayern, Germany |
| Lyell | lyell.com | Lyell Immunopharma is a biotechnology company focused on developing transformative CAR T-cell therapies for patients with solid tumors and hematologic malignancies. Their mission is to defeat cancer through scientific innovation and by delivering advanced cell therapies to patients with unmet medical needs. | South San Francisco, California, United States |
| Triumvira Immunologics | triumvira.com | Triumvira Immunologics is a biotechnology company focused on developing innovative T cell therapies for cancer. They utilize their proprietary T cell Antigen Coupler (TAC) Platform to enhance the immune system's ability to target and destroy cancer cells. Their mission is to bring these advanced therapies to patients | San Francisco, California, United States |
| Moonlight Bio | moonlightbio.us | Moonlight Bio is a biotechnology company focused on developing novel T cell therapies for cancer. They aim to enhance T cell potency by identifying evolutionary adaptations, leading to therapies with improved proliferation, persistence, and function for better patient outcomes. | Seattle, Washington, United States |
| Mongoose Bio | mongoosebio.com | Mongoose Bio is a biotechnology company focused on developing novel cancer therapies. They are pioneering epigenetically programmed memory T cells (Tcm) designed to provide long-lasting immunoprotection against various cancers. Their innovative approach aims to overcome limitations of existing immunotherapies. | Houston, Texas, United States |
| Alloplex Biotherapeutics | alloplexbio.com | Alloplex Biotherapeutics is a biotechnology company focused on developing novel cancer immunotherapies. They utilize a patented cell-retraining platform to engineer cellular therapies, aiming to address unmet needs in cancer treatment. Their lead candidate, SUPLEXA, is an autologous cellular therapy designed to | Boston, Massachusetts, United States |
| Innovative Cellular Therapeutics | ictbio.com | ICT Bio is a biotechnology company focused on developing innovative cellular therapies, specifically CAR-T therapies for solid tumors. Their proprietary CoupledCAR™ platform aims to overcome challenges in treating difficult-to-treat cancers. | Rockville, Maryland, United States |
| TCRCure | tcrcure.com | TCRCure is a pharmaceutical company specializing in the innovation, development, and clinical translation of cellular immunotherapies for cancer treatment. They focus on developing therapies that target specific tumor antigens. | Guangzhou, Guangdong, China |
| Enterome Bioscience | enterome.com | Enterome is a biopharmaceutical company focused on developing off-the-shelf, transformational cancer immunotherapies. They leverage their proprietary OncoMimics™ technology to generate powerful, long-lasting immune responses in patients. | Paris, Ile-de-France, France |
| Anocca | anocca.com | Anocca is a biotechnology company focused on developing precision T-cell immunotherapies, specifically TCR-T cell therapies, for untreatable cancers. They leverage novel biotechnologies and an integrated software ecosystem to create targeted treatments for advanced or difficult-to-treat cancers. | Sodertalje, Stockholm, Sweden |
| Revitope Oncology | revitope.com | Revitope Oncology is a biotechnology company focused on developing novel cancer immunotherapies. They leverage their proprietary TwoGATE™ Technology Platform to achieve precision tumor targeting and create next-generation T cell therapies. Their mission is to advance cancer treatment through innovative immunotherapy | Cambridge, Massachusetts, United States |
| Neogene Therapeutics | neogene.com | Neogene Therapeutics developed novel immuno-oncology T-cell therapies using advanced cell engineering techniques, targeting cancer patients; prior to its acquisition by AstraZeneca, the company likely operated as a pre-revenue biotechnology firm, securing funding through research grants and collaborations. The company's focus was on research and development within a competitive landscape of other immuno-oncology cell therapy developers. | Amsterdam, Noord-Holland, The Netherlands |
| Bristar Immunotech | cn-immunotech.com | Bristar Immunotech is a biotechnology company focused on the development and commercialization of innovative gene-edited T cell immunotherapies. Their pipeline targets hematological tumors, solid tumors, and infectious diseases, aiming to address significant unmet clinical needs. | Beijing, Beijing, China |
Sign up to access the full result set, export, and run custom queries
Start freeGo deeper
Run your own company query with custom filters
This page is a free preview. Sign up to modify criteria, refresh results, and export your shortlist.
Why this is useful
This page helps teams discover companies with similar product and market characteristics to Alaunos Therapeutics.
What Canonical interprets
Canonical translates the query into structured criteria such as company profile, market category, and business model.
How to adapt for your use case
Use this example as a starting point, then refine by geography, employee size, funding stage, or market segment after signup.